Company Xtacy Therapeutics Corp.

Equities

XTCY

CA98423G1072

Investment Management & Fund Operators

Market Closed - Canadian Securities Exchange 11:56:22 2024-04-26 am EDT 5-day change 1st Jan Change
0.045 CAD 0.00% Intraday chart for Xtacy Therapeutics Corp. +50.00% 0.00%

Business Summary

XTACY Therapeutics Corp. is a Canada-based prospect generator that provides high growth companies with financial, operational, and management assistance in the fast-growing market for consumer wellness products. The Company's investment strategy is focused on the specific areas of pain, depression and mental illness. The focus of the Company is on global wellness, psychedelics, mycology, hemp and cannabidiol (CBD), healthcare-related target companies and their clinical studies and trials. By investing in techniques, such as micro-dosing using organic compounds and synthetic molecules, the Company is focusing on the research with the aim of providing wellness benefits with less side effects for people and the planet.

Managers

Managers TitleAgeSince
Chief Executive Officer - 17-11-29
Director of Finance/CFO 70 19-04-09
Corporate Secretary - -

Members of the board

Members of the board TitleAgeSince
Director of Finance/CFO 70 19-04-09
Chief Executive Officer - 17-11-29
Director/Board Member - 19-10-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 54,576,471 48,683,850 ( 89.20 %) 0 89.20 %

Shareholders

NameEquities%Valuation
Meris Kott
11.69 %
5,752,621 11.69 % 1 M $
50,000 0.1016 % 10 000 $
50,000 0.1016 % 10 000 $
Mark Ireton
0.0813 %
40,000 0.0813 % 8 000 $

Company contact information

Xtacy Therapeutics Corp.

1111 Melville Street Suite 100

V6E 3V6, Vancouver

+604-484-0355

http://globalwellnessstrategies.com
address Xtacy Therapeutics Corp.(XTCY)
  1. Stock Market
  2. Equities
  3. XTCY Stock
  4. Company Xtacy Therapeutics Corp.